Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytogen regains rights to ex vivo prostate cancer immunotherapy

Jan. 7, 2003

Results reported for NBI-3001 in glioblastoma

Jan. 7, 2003

Phase I interim safety data reported for Reolysin in malignant glioma

Jan. 7, 2003

Azido-based photosensitizers covered by Mallinckrodt patent

Jan. 3, 2003

Potential antileukemia agents selected from series of arsonic acids

Jan. 3, 2003

Inhibition of tight junction function as a novel approach to breast cancer

Jan. 3, 2003

SuperGen submits first module of rolling NDA for Orathecin

Jan. 3, 2003

Joint development agreement signed by Beaufour Ipsen and Roche for new anticancer drugs

Jan. 3, 2003

Oxigene begins phase II trial of CA4P in thyroid cancer

Jan. 3, 2003

Discovery of Src kinase inhibitors reported by AstraZeneca

Jan. 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...